The flux control coefficient of carnitine palmitoyltransferase I on palmitate beta-oxidation in rat hepatocyte cultures
- PMID: 9173869
- PMCID: PMC1218282
- DOI: 10.1042/bj3230119
The flux control coefficient of carnitine palmitoyltransferase I on palmitate beta-oxidation in rat hepatocyte cultures
Abstract
Two important factors that determine the flux of hepatic beta-oxidation of long-chain fatty acids are the availability of fatty acid and the activity of carnitine palmitoyltransferase I (CPT I). Using Metabolic Control Analysis, the flux control coefficient of CPT I in rat hepatocyte monolayers was determined by titration with 2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate (Etomoxir), which is converted to Etomoxir-CoA, an irreversible inhibitor of CPT I. We measured CPT I activity and flux through beta-oxidation at 0.2 mM and 1.0 mM palmitate to simulate substrate concentrations in fed and fasted states. Rates of beta-oxidation were 4.5-fold higher at 1. 0 mM palmitate compared with 0.2 mM palmitate. Flux control coefficients of CPT I, estimated by two independent methods, were similar: 0.67 and 0.79 for 0.2 mM palmitate, and 0.68 and 0.77 for 1 mM palmitate. It is concluded that the regulatory potential of CPT I is similar at low and high physiological concentrations of palmitate.
Similar articles
-
Comparisons of flux control exerted by mitochondrial outer-membrane carnitine palmitoyltransferase over ketogenesis in hepatocytes and mitochondria isolated from suckling or adult rats.Eur J Biochem. 1999 Feb;259(3):684-91. doi: 10.1046/j.1432-1327.1999.00106.x. Eur J Biochem. 1999. PMID: 10092853
-
Differences between human, rat and guinea pig hepatocyte cultures. A comparative study of their rates of beta-oxidation and esterification of palmitate and their sensitivity to R-etomoxir.Biochem Pharmacol. 1991 Oct 9;42(9):1711-5. doi: 10.1016/0006-2952(91)90506-z. Biochem Pharmacol. 1991. PMID: 1930297
-
Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates.Biochem J. 2009 Apr 15;419(2):447-55. doi: 10.1042/BJ20082159. Biochem J. 2009. PMID: 19138173
-
Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target.Expert Opin Investig Drugs. 2002 Mar;11(3):345-56. doi: 10.1517/13543784.11.3.345. Expert Opin Investig Drugs. 2002. PMID: 11866664 Review.
-
Mitochondrial carnitine palmitoyltransferase-II dysfunction: A possible novel mechanism for nonalcoholic fatty liver disease in hepatocarcinogenesis.World J Gastroenterol. 2023 Mar 28;29(12):1765-1778. doi: 10.3748/wjg.v29.i12.1765. World J Gastroenterol. 2023. PMID: 37032731 Free PMC article. Review.
Cited by
-
Loss of hepatic LRPPRC alters mitochondrial bioenergetics, regulation of permeability transition and trans-membrane ROS diffusion.Hum Mol Genet. 2017 Aug 15;26(16):3186-3201. doi: 10.1093/hmg/ddx202. Hum Mol Genet. 2017. PMID: 28575497 Free PMC article.
-
LRP130 protein remodels mitochondria and stimulates fatty acid oxidation.J Biol Chem. 2011 Dec 2;286(48):41253-41264. doi: 10.1074/jbc.M111.276121. Epub 2011 Oct 4. J Biol Chem. 2011. PMID: 21971050 Free PMC article.
-
The promiscuous enzyme medium-chain 3-keto-acyl-CoA thiolase triggers a vicious cycle in fatty-acid beta-oxidation.PLoS Comput Biol. 2017 Apr 3;13(4):e1005461. doi: 10.1371/journal.pcbi.1005461. eCollection 2017 Apr. PLoS Comput Biol. 2017. PMID: 28369071 Free PMC article.
-
Hepatic adaptations to maintain metabolic homeostasis in response to fasting and refeeding in mice.Nutr Metab (Lond). 2016 Sep 26;13:62. doi: 10.1186/s12986-016-0122-x. eCollection 2016. Nutr Metab (Lond). 2016. PMID: 27708682 Free PMC article.
-
Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes.J Vis Exp. 2021 Sep 9;(175):10.3791/62904. doi: 10.3791/62904. J Vis Exp. 2021. PMID: 34570107 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources